CTC in Predicting Neoadjuvant Chemotherapy Among LABC Patients: a Single-center, Prospective, Exploratory Clinical Trial
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Locally Advanced Breast Cancer|Circulating Tumor Cell
Interventions: DEVICE: GILUPI CellCollector®
Sponsor: RenJi Hospital
Collaborators: Beijing Viroad Biotechnology Co., Ltd.